Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors during the central nervous system, conolidine modulates alternate molecular targets. A Science Improvements study discovered that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availa... https://andynlfyp.tinyblogging.com/how-much-you-need-to-expect-you-ll-pay-for-a-good-conolidin-to-replace-traditional-painkillers-82632404